The carbonic anhydrase activation is involved in the chemopreventive, antitumor effects of non-steroidal anti-inflammatory drugs

Experimental Oncology

Volumn 21, Issue 2, 1999, Pages 121-126

  Puscas, I ^a   Maghiar, A ^a   Coltau, M ^b   Baican, M ^c   Domuta, G ^b  

^a UNIVERSITY OF ORADEA   (Romania)

^b Ctr for Res and Medical Assistance   (Romania)

^c Klinik Wilkenberg   (Germany)

Author keywords

Anti inflammatory drugs; Carbonic anhydrase; Carcinogens; Non steroidal

Indexed keywords

ACETYLSALICYLIC ACID; CARBONATE DEHYDRATASE; CARBONATE DEHYDRATASE II; DIPHENYLAMINE DERIVATIVE; INDOMETACIN; ISOENZYME; N (2 FLUORENYL)ACETAMIDE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL EXPERIMENT; ARTICLE; CHEMOPROPHYLAXIS; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; NONHUMAN; RAT;

EID: 0032778945     PISSN: 02043564     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Thun MJ, Namboodiri MM, Heath CW Jr. Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 1991; 325: 1593-6.
2. Morgan GP, Williams JG. Therapeutic potential of aspirin in cancer of the colon. Br Med J 1993; 307: 1007-8.
3. Oka M, Attwood SE, Kaul B, et al. Immunosuppression in patients with Barrett's esophagus. Surgery 1992; 112: 11-7.
4. Morgan GP, Williams JG. Prostaglandins as mediators of lower esophageal sphincter dysfunction in esophagitis. Gastroenterology 1993; 105: 1266-7.
5. Paganini-Hill A. The role of aspirin in the prevention of colon cancer. In: De Vita VT, Hellman S, Rosemberg SA, Eds. Cancer Prevention, J.B. Lippincott Co, 1993.
6. Labayle D, Fischer D, Vielh P, et al. Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology 1991; 101: 635-9.
7. Reddy BS, Rao CV, Rivenson A, Kelloff G. Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats. Carcinogenesis 1993; 14: 1493-7.
8. Shiff SJ, Rigas B. Nonsteroidal anti-inflammatory drugs and colorectal cancer: evolving concepts of their chemopreventive actions. Gastroenterology 1997; 113: 1992-8.
9. Barnes CJ, Lee M. Chemoprevention of spontaneous intestinal adenomas in the adenomatous polyposis coli Min mouse model with aspirin. Gastroenterology 1998; 114: 873-7.
10. Waddell WR, Loughry RW. Sulindac for polyposis of the colon. J Surg Oncol 1998; 24: 83-7.
11. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 1971; 231: 232-5.
12. Jacoby RF, Marshall DJ, Newton MA, et al. Chemoprevention of spontaneous intestinal adenomas in the Ape Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam. Cancer Res 1996; 56: 710-4.
13. Boolbol SK, Dannenberg AJ, Chadburn A, et al. Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. Cancer Res 1996; 56: 2556-60.
14. Beazer-Barclay Y, Levy DB, Moser AR, et al. Sulindac suppresses tumorigenesis in the Min mouse. Carcinogenesis 1996; 17: 1757-60.
15. DuBois RN, Radhika A, Reddy BS, Entingh AJ. Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. Gastroenterology 1996; 110: 1259-62.
16. Eberhart CE, Coffey RJ, Radhika A, et al. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 1994; 107: 1183-8.
17. Sano H, Kawahito Y, Wilder RL, et al. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res 1995; 55: 3785-9.
18. Kargman SL, O'Neill GP, Vickers PJ, et al. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res 1995; 55: 2556-9.
19. Griffiths JR. Are cancer cells acidic? Br J Cancer 1991; 64: 425-7.
20. Stubbs M. Tumor pH. Lancet 1992; 340: 342-5.
21. Maren TH. Carbonic anhydrase: chemistry, physiology, and inhibition. Physiol Rev 1967; 47: 595-781.
22. Puscas I, et al. Non-steroidal antiinflammatory drugs inhibit cyclooxygenase and activate carbonic anhydrase. In: Carbonic Anhydrase and Modulation of Physiologic and Pathologic Processes in the Organism, Puscas I (ed), Helicon Publ House, Timisoara, Romania, 1994: 339-40.
23. Puscas I, et al. Non-steroidal anti-inflammatory drugs activate carbonic anhydrase by a direct mechanism of action. In: Carbonic Anhydrase and Modulation of Physiologic and Pathologic Processes in the Organism, Puscas I (ed), Helicon Publ House, Timisoara, Romania, 1994: 341-7.
24. Romosan I, Puscas I, et al. Aspirin, an inhibitor of cyclooxygenase, is a direct activator of red cells and gastric mucosa carbonic anhydrase. In: Carbonic Anhydrase and Modulation of Physiologic and Pathologic Processes in the Organism, Puscas I (ed), Helicon Publ House, Timisoara, Romania, 1994: 348-52.
25. Puscas I, Coltau M, Pasca R. Nonsteroidal anti-inflammatory drugs activate carbonic anhydrase by a direct mechanism of action. J Pharmacol Exp Ther 1996; 277: 1464-6.
26. Puscas I, et al. Inhibition of the carbonic anhydrase in the gastric mucosa by prostaglandin E2. Rev Roum Biochem 42: 301-5.
27. Puscas I, Coltau M. Prostaglandins with vasodilating effects inhibit carbonic anhydrase while vasoconstrictive prostaglandins and leukotriens B4 and C4 increase CA activity. Int J Clin Pharmacol Ther 1995; 33: 176-81.
28. Puscas I, et al. Prostaglandins having vasodilating effects inhibit carbonic anhydrase while leukotriens B4 and C4 increase carbonic anhydrase activity. In: Carbonic Anhydrase and Modulation of Physiologic and Pathologic Processes in the Organism, Puscas I (ed), Helicon Publ. House, Timisoara, Romania, 1994: 314-21.
29. Puscas C. Vasodilating prostaglandins inhibit carbonic anhydrase while vasoconstrictive prostaglandins and leukotrienes B4 and C4 activate this enzyme. In vivo and in vitro evidence. The 4th International Conference on the Carbonic Anhydrases. Molecular Biology, Physiology and Clinical Application. Oxford, England, 1995: 1638.
30. Puscas C, Puscas I, et al. Anticancer chemotherapy increases red cell and gastric mucosa carbonic anhydrase. Digestive Disease Week, San Francisco 1996: A579.
31. Puscas C, Puscas I. Carcinogenic substances decrease gastric mucosa and red cell CA II activity. The Forum of Gastroenterology "Banat-Crisana" Timisoara, Romania, 1996.
32. Puscas I, Coltau M, Puscas C. The relationship between CA I, CA II, non-steroidal anti-inflammatory drugs and some carcinogenic substances. Digestive Disease Week, San Diego, 1995: A912.
33. Maghiar T, Puscas I, et al. Non-steroidal anti-inflammatory drugs (NSAIDs) antagonize the effect of certain carcinogenic substances in parallel with some carbonic anhydrase (ca) isozymes activation. The XI World Congress of Gastroenterology, Vienna, 1998.
34. Puscas I, Coltau M, Maghair A, Cladovan C. Inhibition and activation of superoxide dismutase and of carbonic anhydrase in ex vivo with benzo(a)pyrene and cyclophosphamide in patients with gastric cancer as compared to controls. Roman J Gastroenteroloqy 1995.
35. Puscas I, et al. The serum of gastric carcinoma patients explosively activates purified carbonic anhydrase II activity as compared to controls. Method of rapid diagnose of gastric cancer. Digestive Disease Week, Washington DC, USA 1997: 682.
36. Puscas I, et al. The serum of digestive, hepatic and pancreatic cancer patients powerfully activates carbonic anhydrase II. Rapid diagnose method. Multicentric study. Digestive Disease Week, New Orleans, USA 1998: 1445.
37. Puscas I, et al. The serum of digestive and extradigestive carcinoma patients powerfully activates carbonic anhydrase II. Rapid method of diagnosis. Multicentric study. The XI World Congress of Gastroenterology, Vienna, 1998.
38. Khalifah RG. The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C. J Biol Chem 1971; 246: 2561-73.
39. Puscas I, Coltau M, Puscas C. Nicotinates selectively inhibit red cell carbonic anhydrase I. The Nicosilvanil test or in vitro and in ex vivo differentiation of CA I from CA II activity in red cells. The 4th International Conference on the Carbonic Anhydrases. Molecular Biology, Physiology and Clinical Application. Oxford, England 1995: 1630.
40. Lewin MJM. Cell separation. In: Pretlow TG, Pretlow TP, Eds. Methods and Selected Application. New York: Academic Press, 1982: 223-45.
41. Maren TH, Wynns GC, Wistrand PJ. Chemical properties of carbonic anhydrase IV, the membrane-bound enzyme. Mol Pharmacol 1993; 44: 901-5.
42. Sheng H, Shao J, Kirkland SC, et al. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J Clin Invest 1997; 99: 2254-9.
43. Reddy BS, Rao CV, Seibert K. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Cancer Res 1996; 56: 4566-9.
44. Kopp E, Ghosh S. Inhibition of NF-kappa B by sodium salicylate and aspirin. Science 1994; 265: 956-9.
45. Schwenger P, Bellosta P, Vietor I, et al. Sodium salicylate induces apoptosis via p38 mitogen-activated protein kinase but Inhibits tumor necrosis factor-induced c-Jun N-terminal kinase/stress-activated protein kinase activation. Proc Natl Acad Sci USA 1997; 94: 2869-73.
46. Lehmann JM, Lenhard JM, Oliver BB, et al. Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs. J Biol Chem 1997; 272: 3406-10.
47. Mitchell JA, Akarasereenont P, Thiemermann C, et al. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci USA 1994; 90: 11693-7.
48. Puscas I, Vlaicu R, Lazar A. Isosorbide nitrates, nitroglycerin, and sodium nitroprusside induce vasodilation concomitantly with inhibition of carbonic anhydrase I in erythrocytes. Am J Hypertens 1997; 10: 124-8.
49. Leffler CW, Mirro R, Shibata M, et al. Effects of indomethacin on cerebral vasodilator responses to arachidonic acid and hypercapnia in newborn pigs. Pediatr Res 1993; 33: 609-14.